Clinical Trial Update: Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA [Phase 3]

View source ↗

Summary

Phase 3 study evaluating two doses of a rotavirus vaccine given with or around routine infant vaccines in healthy US infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• Human Rotavirus Vaccine (HRV) (rotavirus vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 3 | Status: COMPLETED